$28.475
1.415[5.23%]
Last update: 11:20AM Get Real Time Here
Arcturus Therapeutics
(NASDAQ:ARCT)Arcturus Therapeutics Stock (NASDAQ:ARCT), Quotes and News Summary
Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
| Open | $27.030 |
| Close | - |
| Volume / Avg. | 86.918K / 481.056K |
| Day Range | 27.030 - 28.650 |
| 52 Wk Range | 17.520 - 43.810 |
| Market Cap | $766.412M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 23.8% |
| Days to Cover | 8.25 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Arcturus Therapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare dise...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arcturus Therapeutics (ARCT) stock?
You can purchase shares of Arcturus Therapeutics (NASDAQ: ARCT) through any online brokerage.
Who are Arcturus Therapeutics's (ARCT) competitors?
Other companies in Arcturus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT) and Sage Therapeutics (NASDAQ:SAGE).
What is the target price for Arcturus Therapeutics (ARCT) stock?
The latest price target for Arcturus Therapeutics (NASDAQ: ARCT) was reported by HC Wainwright & Co. on Wednesday, March 20, 2024. The analyst firm set a price target for 60.00 expecting ARCT to rise to within 12 months (a possible 110.71% upside). 20 analyst firms have reported ratings in the last year.
Current Stock Price for Arcturus Therapeutics (ARCT)?
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $28.475 last updated Today at April 23, 2024 at 11:20 AM EDT.
Does Arcturus Therapeutics (ARCT) pay a dividend?
There are no upcoming dividends for Arcturus Therapeutics.
When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?
Arcturus Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is Arcturus Therapeutics (ARCT) going to split?
There is no upcoming split for Arcturus Therapeutics.
What sector and industry does Arcturus Therapeutics (ARCT) operate in?
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.